Company profile

Exo Inc

Medical Imaging & Radiology

Company profile

About Exo Inc

Exo Inc is a medical imaging technology company pioneering an AI-powered point-of-care ultrasound (POCUS) platform that makes whole-body ultrasound accessible across healthcare settings. The company's flagship product, Exo Iris, is a pocket-sized, three-in-one handheld ultrasound device built on proprietary Piezoelectric Micromachined Ultrasonic Transducer (pMUT) silicon chip technology. This breakthrough approach combines the imaging excellence of piezoelectric crystals with the affordability and scalability of silicon manufacturing, featuring 4096 individual pMUTs that deliver ultra-high dynamic range imaging. Exo's comprehensive ecosystem includes SweepAI, an FDA-cleared real-time AI system that automatically labels anatomy, captures optimal views, and provides instant measurements without requiring internet connectivity. The platform also features Exo U, an AI-powered scan tutor that guides clinicians through proper probe motion and anatomy identification, and Exo Works, a device-agnostic workflow software that streamlines documentation, quality assurance, billing, and team collaboration. The company delivers FDA-cleared AI insights across multiple clinical applications including cardiac assessment (automated ejection fraction, chamber sizing, strain analysis), lung pathology detection (B-lines, effusions, consolidations), fluid management (IVC collapsibility, bladder volume), and population health screening. Exo serves health systems, hospitals, critical care units, emergency departments, sports medicine, rheumatology, and medical education programs. The platform is designed to replace traditional ultrasound carts and multiple probes with a single integrated solution that combines high-performance imaging, real-time AI guidance, and simplified workflows to enable confident care delivery at the point of need.

Company description Exo Inc official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Exo Inc?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • atelectasis
  • cardiac hypertrophy
  • cardiotoxicity
  • fluid management
  • Heart failure (CHF, HFpEF, HFrEF)
  • hip dysplasia screening
  • hypertension
  • lung consolidations
  • lung edema
  • pleural effusions
  • structural heart disease
  • thyroid cancer screening

Who it serves

  • Critical Care Units
  • Emergency Departments
  • Health Systems
  • Hospitals
  • Medical Education Programs
  • Neurology
  • Pediatric Critical Care
  • Rheumatology
  • Sports Medicine
  • Women's Health

Deployment & integration

Cloud Saas · Embedded deployment with recorded integration context.

Recorded integration context: device-agnostic ultrasound machine connectivity, EHR systems, PACS (Picture Archiving and Communication System).

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

FDA clearance for pleural effusion and consolidation/atelectasis AI (June 2025); Samsung Medison strategic partnership with Omar Ishrak joining board (May 2025); FDA clearance for HFpEF and cardiotoxicity indicators (April 2025); FDA clearance for SweepAI with hemodynamics and hypertension AI (December 2024); Geisinger deployment across 6 institutes, 10 hospital campuses, 86 connected machines

Partnerships

Recorded partners

  • Geisinger Health System
  • Samsung Medison (strategic partnership announced May 2025)
  • Wellstar MCG Health

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Exo Iris

Pocket-sized AI ultrasound that replaces carts and probes for faster scans, simpler workflows, confident care

Device · EmbeddedCompany source

Exo Silicon (pMUT Technology)

Piezoelectric Micromachined Ultrasonic Transducer chip technology for ultrasound imaging

Device · EmbeddedCompany source

Exo U

AI coach that guides probe motion, reveals anatomy, and teaches as you scan

Software · EmbeddedCompany source

Exo Works

Mobile-first, cloud-based POCUS workflow solution for documentation, billing, and QA

Platform · Cloud SaaSCompany source

Exo Works Connect

Rapid deployment solution for POCUS programs in healthcare organizations

Platform · Cloud SaaSCompany source

SweepAI

AI that auto-labels anatomy, auto-captures key views, and auto-measures precisely, even offline

Software · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

40% increase in completed ultrasound exam documentation

Geisinger Critical Care department

50% reduction in documentation time

Geisinger MSK Sports Medicine department

3x increase in POCUS exams performed monthly

Geisinger Rheumatology department

47% increase in revenue capture

Wellstar MCG Health

LVEF RMSE 7.29-7.58% across views

Published validation study

83-91% accuracy detecting low EF (<50%)

Published validation study

Geisinger

Enterprise POCUS workflow implementation across multiple departments and campuses to improve ultrasound documentation, billing, and quality assurance

40% increase in completed ultrasound exam documentation in Critical Care; 50% reduction in documentation time in MSK Sports Medicine; 3x increase in monthly POCUS exams in Rheumatology; 86 ultrasound machines connected across 6 institutes and 10 hospital campuses

Wellstar MCG Health

Implementation of Exo Works to accelerate patient care and streamline exam documentation, QA, regulatory compliance, and revenue capture

47% increase in revenue capture

OSF HealthCare - St Francis Medical Center

Point-of-care ultrasound workflow solution implementation

Solved infrastructure challenges for effective POCUS deployment

West Virginia University Medical Center

Medical education and student training for point-of-care ultrasound

Reduced feedback time from over 1 hour to a few minutes for student ultrasound review

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Dornoosh Zonoobi

CEO of Medo (acquired by Exo)

Omar Ishrak

Board Member

06 · Company updates

Updates from Exo Inc

Recent articles published on Exo Inc's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon